Splicing-factor alterations in cancers.
Document Type
Article
Publication Date
9-2016
JAX Location
Reprint Collection
JAX Source
RNA 2016 Sep; 22(9):1285-301
Volume
22
Issue
9
First Page
1285
Last Page
1301
ISSN
1469-9001
PMID
27530828
Abstract
Tumor-associated alterations in RNA splicing result either from mutations in splicing-regulatory elements or changes in components of the splicing machinery. This review summarizes our current understanding of the role of splicing-factor alterations in human cancers. We describe splicing-factor alterations detected in human tumors and the resulting changes in splicing, highlighting cell-type-specific similarities and differences. We review the mechanisms of splicing-factor regulation in normal and cancer cells. Finally, we summarize recent efforts to develop novel cancer therapies, based on targeting either the oncogenic splicing events or their upstream splicing regulators. RNA 2016 Sep; 22(9):1285-301
Recommended Citation
Anczuków O,
Krainer A.
Splicing-factor alterations in cancers. RNA 2016 Sep; 22(9):1285-301